Search

everythinglearnresearchcommunity

for

Search:↓

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

Teak leaf extract may effectively and safely promote hair growth in males with androgenic alopecia.

Oral spironolactone may be effective for female pattern hair loss with a low rate of side effects.

Plum-blossom needling with conventional treatments improves hair regrowth in alopecia areata.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

PRP shows promise for treating female hair loss but needs more research.

Platelet-rich plasma therapy helps increase hair density in male patients with hair loss but doesn't change hair thickness.

Licorice has many health benefits but should be used carefully due to possible side effects.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.

PRP is an effective and safe treatment for female hair loss.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

The moisturizing cream used after a chemical peel was well tolerated and effectively moisturized the skin.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

Platelet-rich plasma treatment is generally safe and effective for hair loss, acne scars, skin discoloration, and facial rejuvenation, but deeper injections are better and multiple treatments can increase risk of side effects.

Treating underlying metabolic and hormonal issues is key to managing female hair loss.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.